Case Comprehensive Cancer Center and Case Western Reserve University Receive Prestigious Grant to Study Esophageal Cancer
October 6, 2011
The Case Comprehensive Cancer Center and Case Western Reserve University (CWRU) School of Medicine are proud to announce the receipt of a highly competitive $5.4 million grant to study genetic determinants of Barrett's esophagus and esophageal adenocarcinoma. This five-year award from the National Cancer Institute will support the Barrett's Esophagus Translational Research Network (BETRNet), which consists of multiple centers collaborating to develop an understanding of the basis of Barrett's esophagus and its conversion to esophageal carcinoma. Researchers will also work to determine the role genetics and environmental factors play in the development and progression of these diseases, with the ultimate goal of reducing the mortality associated with this deadly cancer.
Case Comprehensive Cancer Center Receives $11.3 Million to Establish GI SPORE- GI Cancers Research Center
September 16, 2011
The Case Comprehensive Cancer Center has been awarded an $11.3 million research grant to establish a GI SPORE- GI Cancers Research Center at Case Western Reserve University. With this designation, Case joins only six other nationally recognized GI SPORE Centers of Excellence in the country. Researchers from CWRU, University Hospitals Seidman Cancer Center and Cleveland Clinic, all members of the cancer center, collaborate in the research effort.
Case CCC American Cancer Society (ACS) Institutional Research Grant (IRG) Pilot Awards
September 16, 2011
Congratulations to the recent recipients of the Case CCC ACS IRG pilot awards:
Brian Bolwell, MD Appointed Director for the Taussig Cancer Institute
July 28, 2011
Cleveland Clinic has appointed Brian J. Bolwell, MD, as chairman of the Taussig Cancer Institute. Dr. Bolwell is an international leader in the management of hematologic malignancies and bone marrow transplantation. His research in disorders of blood and bone marrow cells has resulted in significant clinical advances and expanded the scope of stem cell transplantation for patients who were previously ineligible for this life-saving treatment.
Jaroslaw Maciejewski, MD, PhD Appointed Associate Director for the Lerner Research Institute, Case Comprehensive Cancer Center
July 5, 2011
Stan Gerson, MD, Director of the Case Comprehensive Cancer Center, announces the appointment of Jaroslaw Maciejewski, MD, PhD as Associate Director for the Lerner Research Institute. Dr. Maciejewski will join the senior leaders of the Cancer Center coordinating the overall cancer research effort of the members of the Cancer Center who are faculty at CWRU, University Hospitals, and Cleveland Clinic...
New Study Shows Blood Pressure Increase Indicates Treatment Response
April 29, 2011
Patients who develop high blood pressure while being treated for advanced kidney cancer with the drug sunitinib respond better to treatment, maintain longer progression-free survival, and survive longer, according to a Cleveland Clinic-led study.
The study, published today in The Journal of the National Cancer Institute, demonstrates that high blood pressure (hypertension) is a significant independent predictor of improved outcomes for patients with metastatic renal cell carcinoma....
Ruth Keri PhD, Appointed Associate Director for Basic Research, Case Comprehensive Cancer Center
March 28, 2011
After a national search, I am delighted to announce the appointment of Ruth Keri, PhD to the position of Associate Director for Basic Research, Case Comprehensive Cancer Center. Dr. Keri is an associate professor in the departments of pharmacology, genetics and oncology at CWRU. She received her PhD in the department of pharmacology here in 1992, working at the time on identifying the regulatory mechanisms underlying pituitary gonadotropin hormone gene expression using novel transgenic mouse models...
Lack of sleep found to be a new risk factor for colon cancer
February 8, 2011
In a ground-breaking new study published in the Feb. 15, 2011 issue of the journal Cancer, researchers from University Hospitals (UH) Case Medical Center and Case Western Reserve University School of Medicine, found that individuals who averaged less than six hours of sleep at night had an almost 50 percent increase in the risk of colorectal adenomas compared with individuals sleeping at least seven hours per night. Adenomas are a precursor to cancer tumors, and left untreated, they can turn malignant...
Case CCC Members Named AAAS Fellows
February 7, 2011
In December 2010, 503 individuals were elected as Fellows of the American Association for the Advancement of Science (AAAS). The Case CCC is honored to have four members recognized for their contributions to science and technology: Drs. James Anderson for Engineering, Ram Ganapathi for Pharmaceutical Sciences, and Thomas Hamilton and Qing Wang for Medical Sciences. In addition, Dr. Eileen White, who has served on the Case CCC External Advisory Board since 2009, was also recognized for her work in the Medical Sciences.
New clinical trial to determine ovarian cancer risks in African-American women
February 1, 2011
University Hospitals Case Medical Center and Case Western Reserve University School of Medicine are conducting an important new study addressing the lack of knowledge about causes and risk factors for ovarian cancer in African American women. The five-year study is funded by the National Cancer Institute through Case Western Reserve University School of Medicine...
Brian J. Bolwell, MD Appointed Associate Director for the Taussig Cancer Institute
January 17, 2011
Stan Gerson, MD, Director of the Case Comprehensive Cancer Center, announces the appointment of Brian J. Bolwell, MD as Associate Director for the Taussig Cancer Institute. Dr. Bolwell will join the senior leaders of the Cancer Center coordinating the overall cancer research effort of the 364 members of the Cancer Center who are faculty at CWRU, University Hospitals, and Cleveland Clinic...
For more Cancer Center news, please see the Weekly Newsletter.